A citation-based method for searching scientific literature




Patrick M Moriarty, Paul D Thompson, Christopher P Cannon, John R Guyton, Jean Bergeron, Franklin J Zieve, Eric Bruckert, Terry A Jacobson, Stephen L Kopecky, Marie T Baccara-Dinet, Yunling Du, Robert Pordy, Daniel A Gipe. J Clin Lipidol 2015
Times Cited: 301




List of shared articles



Times cited

Contemporary Management of Dyslipidemia.
Richard A Ferraro, Thorsten Leucker, Seth S Martin, Maciej Banach, Steven R Jones, Peter P Toth. Drugs 2022
1

Emerging views of statin pleiotropy and cholesterol lowering.
Dongbo Yu, James K Liao. Cardiovasc Res 2022
12

Statin-associated muscle symptoms-A review: Individualizing the approach to optimize care.
Barbara S Wiggins, James M Backes, Daniel Hilleman. Pharmacotherapy 2022
0


2021 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in Adults.
Glen J Pearson, George Thanassoulis, Todd J Anderson, Arden R Barry, Patrick Couture, Natalie Dayan, Gordon A Francis, Jacques Genest, Jean GrĂ©goire, Steven A Grover,[...]. Can J Cardiol 2021
74

Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) inhibitors and the risk for neurocognitive adverse events: A systematic review, meta-analysis and meta-regression.
Bruria Hirsh Raccah, Alona Yanovsky, Nir Treves, Victoria Rotshild, Christel Renoux, Haim Danenberg, Ran Eliaz, Ilan Matok. Int J Cardiol 2021
2

Efficacy and Safety of PCSK9 Inhibitors in Stroke Prevention.
Bayan Moustafa, Fernando D Testai. J Stroke Cerebrovasc Dis 2021
0